3 - Epidemiology and Public Health Flashcards

1
Q

Provide the highest level of proof of an effect by minimizing bias

A

Internal validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generalizability

A

External validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Attribute that increases the likelihood of developing a disease

A

Risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Occurs when an attribute or other factor is found to be related to an outcome of interest

A

Association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Systematic error that causes the results of a study to deviate from the truth

A

Bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ultimate problem with bias

A

Can’t be measured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Occurs when two risk factors or exposures are associated with each other and the outcome of interest

A

Confounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Measure of an effect in an ideal setting

A

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If the study was repeated using the same study design and the same cohort, the same results would be found

A

Internally valid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Studies that measure efficacy

A

Explanatory studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How well an intervention works in the real world

A

Effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Studies that compare two or more treatments that are generally accepted to be effective

A

Comparative effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Studies that lack the regulatory oversight that is required by federal agencies when treatments receive initial approval

A

Pragmatic studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

First studies performed in humans

A

Phase I studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Evaluate a drug’s dose, range, safety, tolerability, pharmacokinetics, and pharmacodynamics

A

Phase I studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Also called initial efficacy studies

A

Phase II studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Determine the effect of an intervention in patients with the disease of interest

A

Phase II studies

18
Q

Also called comparative efficacy studies

A

Phase III studies

19
Q

Assess the efficacy of an intervention compared with that of a “control” treatment

A

Phase III studies

20
Q

Sometimes called, pivotal studies, provide the data necessary for regulatory agencies to decide whether or not to approve a dug

A

Phase III studies

21
Q

Also called postmarketing studies or effectiveness studies

A

Phase IV studies

22
Q

Also known as large sample studies or Peto studies

A

Pragmatic trials

23
Q

Effectiveness studies that focus on understanding how an intervention works in the routine clinical setting

A

Pragmatic trials

24
Q

Cohort vs case-control study

A

Cohort: prospective

Case-control: retrospective

25
Meta-analytic technique that enables comparisons between treatments that were never directly compare in individual studies
Network of evidence or mixed treatment comparison
26
Frequency of a disease or other outcome of interest over a given period of time
Prevalence
27
Number of individuals with a disease divided by the number of individuals sampled over a specified time period
Prevalence
28
Frequency of new cases of a disease or other outcome anong those who are at risk of the disease or outcome of interest within a specified period of time
Incidence
29
Dividing the number of individuals who developed sa disease by the number of individuals in the at-risk population
Incidence
30
Ratio of how an outcome is measured in those with a disease versus those without a disease
Risk ratio or relative risk or hazard ratio
31
Absolute risk in the exposed persons minus the absolute risk in the nonexposed persons
Attributable risk or risk difference
32
Ratio of the odds that a case is exposed compared with the odds that a control is exposed
Odds ratio
33
Relationship of odds ratios and relative risk when the outcome is rare
Equivalent
34
Relationship of odds ratios and relative risk when the outcome is common
Odds ratio overestimates the relative risk
35
Proportion of truly diseased individuals who are defined as having disease by a test
Sensitivity
36
Also called true positive rate
Sensitivity
37
Proportion of individuals who truly do not have the disease who are defined by the test as not having the disease
Specificity
38
Also called true negative rate
Specificity
39
Proportion of individuals who have a positive test that truly have the disease
Positive predictive value
40
Proportion of individuals who have a negative test that truly do not have the disease
Negative predictive value